France launches biotech fund

Experts say new fund not sufficient to address chronic biotech funding shortage

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The French government has launched a new investment fund to attract capital to the country's languishing medium-sized biotech companies. However, scientists argue that the fund is not nearly generous enough to help ease the chronic investment shortage for French biotech companies hoping to grow into global players.

The fund -- termed the fund of funds for technology (le Fonds de Fonds Technologique (FFT)) - plans to spend 150 million euros each year over the next three years, matching VC investments in medium-sized companies that have the potential to go to the stock market. In contrast to previous funds, which have distributed funding more equally among companies, the FFT will support VCs targeting companies that have been identified as innovative and most likely to bring new products to the market according to the highly competitive criteria of the European Investment Bank, which is itself contributing 50 million euro to the FFT.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jane Burgermeister

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio